Table 2.
Summary of molecules for targeting phase-separation for treating treatment-resistant malignancy.
| Protein complex | Molecules/Screning | Molecular function | Tumor model | Ref |
|---|---|---|---|---|
| HOXB8/FOSL1 | GSK-J4 Screening by 303 chemicals |
H3K27 demethylase inhibitor | Osteosarcoma | 118 |
| SRC3/NSD2 | SI-2 High throughput cell-based luciferase assay screening |
small molecules interacting with SRC-3 |
Multiple myeloma | 119, 120 |
| OCT4/AR/FOXA1 OCT4/NRF1 |
Ribavirin In silico screening by using Connectivity Map |
nuclear analogue | Prostate cancer | 81, 113 |
| YAP/TAZ/SRC1 | Elvitegravir YAP reporter cell-based screening |
integrase inhibitor | Lung cancer | 121 |